LifeStance Health Group, Inc. (NASDAQ:LFST) Given Consensus Recommendation of “Moderate Buy” by Brokerages

LifeStance Health Group, Inc. (NASDAQ:LFST) has received a consensus rating of “Moderate Buy” from the eleven ratings firms that are covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation, six have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $11.50.

Several brokerages recently issued reports on LFST. Zacks Research downgraded LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a report on Monday, July 13th. Wall Street Zen cut LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Barclays lifted their price objective on shares of LifeStance Health Group from $9.00 to $13.00 and gave the stock an “overweight” rating in a report on Tuesday, July 14th. BTIG Research upped their target price on shares of LifeStance Health Group from $12.00 to $15.00 and gave the stock a “buy” rating in a research note on Friday. Finally, The Goldman Sachs Group began coverage on shares of LifeStance Health Group in a report on Friday, June 5th. They issued a “neutral” rating and a $9.00 target price for the company.

LifeStance Health Group Stock Performance

Shares of LFST opened at $10.90 on Wednesday. The firm has a market capitalization of $4.23 billion, a P/E ratio of 181.67 and a beta of 1.12. LifeStance Health Group has a 52 week low of $3.74 and a 52 week high of $11.76. The stock has a 50 day moving average price of $9.33 and a two-hundred day moving average price of $7.82. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.48 and a current ratio of 1.48.

LifeStance Health Group (NASDAQ:LFST) last posted its earnings results on Wednesday, May 6th. The company reported $0.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.03. The company had revenue of $403.48 million for the quarter, compared to analyst estimates of $387.46 million. LifeStance Health Group had a return on equity of 1.56% and a net margin of 1.55%.The business’s quarterly revenue was up 21.2% compared to the same quarter last year. Equities analysts forecast that LifeStance Health Group will post 0.12 earnings per share for the current fiscal year.

Insider Buying and Selling

In other LifeStance Health Group news, Director Darren M. Black sold 5,899,661 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $8.02, for a total value of $47,315,281.22. Following the completion of the sale, the director directly owned 23,310,115 shares of the company’s stock, valued at approximately $186,947,122.30. This represents a 20.20% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Eric Shuey sold 243,362 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $8.02, for a total transaction of $1,951,763.24. Following the completion of the sale, the director owned 867,562 shares of the company’s stock, valued at approximately $6,957,847.24. This trade represents a 21.91% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 7,687,394 shares of company stock worth $63,579,701. 3.50% of the stock is owned by insiders.

Institutional Trading of LifeStance Health Group

A number of institutional investors and hedge funds have recently modified their holdings of the business. Larson Financial Group LLC lifted its holdings in LifeStance Health Group by 19,952.6% during the fourth quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after acquiring an additional 3,791 shares during the period. KBC Group NV bought a new position in LifeStance Health Group in the 1st quarter valued at $29,000. EverSource Wealth Advisors LLC grew its stake in LifeStance Health Group by 359.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock valued at $44,000 after purchasing an additional 5,404 shares during the period. PNC Financial Services Group Inc. increased its position in shares of LifeStance Health Group by 615.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock valued at $59,000 after purchasing an additional 7,987 shares during the last quarter. Finally, Assetmark Inc. increased its position in shares of LifeStance Health Group by 17.0% during the 1st quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock valued at $60,000 after purchasing an additional 1,367 shares during the last quarter. 85.50% of the stock is owned by hedge funds and other institutional investors.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.